Xenon Pharmaceuticals grants 39,250 share options to 5 new employees on Dec 4, 2025, as inducements for joining.

Xenon Pharmaceuticals Inc., a biopharmaceutical company based in Vancouver and Boston, revealed on December 4, 2025, that it has granted equity awards to five new non-officer employees. The grants include a total of 39,250 share options. These inducement grants were officially authorized by the Compensation Committee of the company's Board of Directors. The options were provided as a way to attract these employees to join the company and are considered significant inducements in line with Nasdaq Listing Rule 5635(c)(4).